Adelaide Research & Scholarship: Search

Search

Results 61-70 of 97 (Search time: 0.002 seconds).

previous
1
...
4
5
6
7
8
9
10
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2009	Dasatinib-associated major molecular responses in patients with chronic myeloid leukemia in chronic phase following imatinib failure: response dynamics and predictive value	Hochhaus, A.; Muller, M.; Radich, J.; Branford, S.; Kantarjian, H.; Hanfstein, B.; Rousselot, P.; Kim, D.; Lipton, J.; Bleickhardt, E.; Lambert, A.; Hughes, T.
	2010	Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCR	Ross, D.; Branford, S.; Seymour, J.; Schwarer, A.; Arthur, C.; Bartley, P.; Slader, C.; Field, C.; Dang, P.; Filshie, R.; Mills, A.; Grigg, A.; Vaz de Melo, J.; Hughes, T.
	2005	Dynamics of chronic myeloid leukaemia	Michor, F.; Hughes, T.; Iwasa, Y.; Branford, S.; Shah, N.; Sawyers, C.; Nowak, M.
	2006	Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemia	Branford, S.; Cross, N.; Hochhaus, A.; Radich, J.; Saglio, G.; Kaeda, J.; Goldman, J.; Hughes, T.
	2011	Mutational analysis in chronic myeloid leukemia: When and what to do?	Branford, S.; Hughes, T.
	2010	Practical considerations for monitoring patients with chronic myeloid leukemia	Branford, S.; Hughes, T.
	2003	Molecular monitoring of chronic myeloid leukemia	Hughes, T.; Branford, S.
	2003	Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia	Hughes, T.; Kaeda, J.; Branford, S.; Rudzki, Z.; Hochhaus, A.; Hensley, M.; Gathmann, I.; Bolton, A.; van Hoomissen, I.; Goldman, J.; Radich, J.
	2009	Harmonization of molecular monitoring of CML therapy in Europe	Muller, M.; Cross, N.; Erben, P.; Schenk, T.; Hanfstein, B.; Ernst, T.; Hehlmann, R.; Branford, S.; Saglio, G.; Hochhaus, A.
	2002	Dual transcription of b2a2 and b3a2 BCR-ABL transcripts in chronic myeloid leukaemia is confined to patients with a linked polymorphism within the BCR gene	Branford, S.; Hughes, T.; Rudzki, Z.